中文名:伯舒替尼 (SKI-606)
英文名:Bosutinib (SKI-606)
中文别名:伯舒替尼
英文别名:SKI-606|WAY-173606|Bosutinib,SKI-606|BSPBio_001023|NCGC00241107-03|NSC799367|NSC-799367|4-(2,4-Dichloro-5-methoxy-phenylamino)-6-methoxy-7-[3-(4-methyl-piperazin-1-yl)propoxy]quinoline-3-carbonitrile|5018V4AEZ0|DB06616|SK 606|2-[4-(2,3-dihydro-1,4-benzodi
纯度:≥99%
货号:B129905
包装:10mg、50mg、100mg
Cas号:380843-75-4
产品介绍:
Bosutinib (SKI-606) is a potent c-Abl, Bcr-Abl, and Src-Abl kinase inhibitor, shown to effectively interfere with the progress of chronic myelogenous leukemia (CML). In a competitive study with Imatinib, Bosutinib was shown to inhibit Bcr-Abl kinase activity in CD34+ CML cells more potently than Imatinib. Activity of Src-Abl has been implicated in the development of other non-CML malignancies, and Bosutinib has demonstrated in studies to suppress breast cancer growth and migration.A c-Abl, Src-Abl, and Bcr-Abl inhibitor
查看阿拉丁官网此产品相关对应页面:https://www.aladdin-e.com/zh_cn/B129905.html
关键字: 伯舒替尼;SKI-606;WAY-173606;Bosutinib,SKI-606
上海阿拉丁生化科技股份有限公司是A股上市公司((股票代码:688179),专注于科研试剂的研发、生产和销售,已陆续建立多个工厂和研发中心。作为领军企业,阿拉丁始终坚持质量第一,连续13年被评为“最受欢迎试剂品牌”。
阿拉丁目前常备库存试剂产品品种超过7万种,SKU总数超过46万,产品线涵盖了化学试剂、生化试剂、药靶配体、蛋白质和抗体等多个领域,是国内少数化学试剂到生物试剂全面发展的国产试剂品牌,产品同步发布在我们国内(www.aladdin-e.com)和海外(www.aladdinsci.com)电商平台。